Candel Therapeutics, Inc. CADL Capital investments accrued but not yet paid
Capital investments accrued but not yet paid at other companies
Other financials
Where this comes from
Reported directly by Candel Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CapitalExpendituresIncurredButNotYetPaid.
The official record: Candel Therapeutics, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Candel Therapeutics, Inc.'s capital investments accrued but not yet paid.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Candel Therapeutics, Inc.'s capital investments accrued but not yet paid?
- Candel Therapeutics, Inc. (CADL) reported capital investments accrued but not yet paid of $39K in Q1 2026.
- How has Candel Therapeutics, Inc.'s capital investments accrued but not yet paid changed year-over-year?
- Candel Therapeutics, Inc.'s capital investments accrued but not yet paid increased by 143.8% year-over-year, from $16K to $39K.